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ASF/SF2-Regulated CaMKII Alternative
Splicing Temporally Reprograms
Excitation-Contraction Coupling in Cardiac Muscle
Introduction
Alignment of numerous cDNAs andexpressed sequence
tags (ESTs) to finished genomes have revealed that al-
ternative splicing is a prominent feature of the tran-
Xiangdong Xu,1,6 Dongmei Yang,4,6 Jian-Hua Ding,1
Wang Wang,4 Pao-Hsien Chu,2,7 Nancy D. Dalton,2
Huan-You Wang,1,8 John R. Bermingham Jr.,3,9
Zhen Ye,1 Forrest Liu,3 Michael G. Rosenfeld,3
James L. Manley,5 John Ross Jr.,2 Ju Chen,2
scriptome in higher eukaryotic cells, with estimation ofRui-Ping Xiao,4 Heping Cheng,4
more than half of human genes expressing multipleand Xiang-Dong Fu1,*
mRNA isoforms (Modrek et al., 2001). Alternative splic-1Department of Cellular and Molecular Medicine
ing can alter the structure of encoded proteins, thereby2Department of Medicine and Institute
dramatically enlarging the complexity of the proteome,of Molecular Medicine
or modify the stability, transport, localization, and trans-3Department of Medicine and Howard Hughes
lational efficiency of specific transcripts as a means toMedical Institute
regulate gene expression (Black, 2003). In mammalianUniversity of California, San Diego
systems, the most rigorous functional test of the signifi-9500 Gilman Drive
cance of specific alternative splicing events is throughLa Jolla, California 92093
isoform-specific gene targeting, which has been applied4Laboratory of Cardiovascular Science
to only four genes including Agrin (Burgess et al., 1999),National Institute on Aging
FGFR2 (De Moerlooze et al., 2000; Hajihosseini et al.,National Institutes of Health
2001), WT1 (Hammes et al., 2001), and, more recently,Baltimore, Maryland 21224
fibronectin (Muro et al., 2003). In each case, selective5Department of Biological Sciences
inactivation of a specific mRNA isoform led to a clearColumbia University
phenotype in development or organ physiology, demon-715 Fairchild Building
strating that the splice choices under investigation areNew York, New York 10027
indeedbiologically significant and thusmustbe tightly reg-
ulated.
Understanding of how splicing is regulated has been
a major goal in molecular biology, and, thus far, verySummary
little is known about regulated splicing in a physiological
context. In this regard, the best-understood cases re-The transition from juvenile to adult life is accompa-
main in the Drosophila system, where powerful genetic
nied by programmed remodeling in many tissues and
approaches were first used to identify specific splicing
organs, which is key for organisms to adapt to the regulators and their downstream targets followed by
demand of the environment. Here we report a novel biochemical dissection of the regulatory mechanisms
regulated alternative splicing program that is crucial (Lopez, 1998). Inmammalian systems,most splicing fac-
for postnatnal heart remodeling in themouse.We iden- tors and regulators were biochemically identified and
tify the essential splicing factor ASF/SF2 as a key com- characterized based on minigene models. A few of the
ponent of the program, regulating a restricted set of best-characterized factors include the serine/arginine
tissue-specific alternative splicing events during heart (SR)-rich family of splicing factors, hnRNP A1, PTB, TIA,
remodeling. Cardiomyocytes deficient in ASF/SF2 dis- and members of the CELF family (Black, 2003). Vital
play an unexpected hypercontraction phenotype due roles of these splicing regulators in biological pathways
to a defect in postnatal splicing switch of the Ca2/ are just beginning to be understood.
calmodulin-dependent kinase II (CaMKII) transcript. SR proteins are conserved through metazoans, and
This failure results in mistargeting of the kinase to their functions have been extensively studied. They are
sarcolemmal membranes, causing severe excitation- essential for constitutive splicing in vitro and capable
contraction couplingdefects. Our results validateASF/ of influencing splice site choices both in vitro and in
SF2 as a fundamental splicing regulator in the repro- transfected cells, thus qualifying them as a family of
gramming pathway and reveal the central contribution splicing regulators (Black, 2003). More recently, the
function of SR proteins has been extended to mRNAof ASF/SF2-regulated CaMKII alternative splicing to
export (Huang and Steitz, 2001; Huang et al., 2003b,functional remodeling in developing heart.
2004; Lai and Tarn, 2004), mRNA stability (Lemaire et
al., 2002), and protein translation (Sanford et al., 2004).
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Wang et al., 2001). More recently, we have developed ures 1A–1C). The floxedASF/SF2allelewas converted to
null mutation in the germline, and homozygous deletionthe heart as an experimental system for in vivo studies of
splicing regulation in which analysis of cellular functions caused early embryonic lethality (see Supplemental Ta-
bleS1at http://www.cell.com/cgi/content/full/120/1/59/can be carried out without complications associated
with defects in cell proliferation, becauseadult cardiomyo- DC1/). These results demonstrate the essential role of
this splicing factor in mouse development. Previously,cytes are largely nondividing cells (Ding et al., 2004). In
addition, the contractile apparatus and the regulatory both SRp20 (Jumaa et al., 1999) and SC35 (Wang et
al., 2001) ko were shown to have the same early lethalcircuitry in the heart are well characterized, and a wide
range of analytical tools for heart physiology is available phenotype, together suggesting a fundamental and non-
redundant function for each SR protein inmouse embry-for functional dissection in normal and disease state
(Chien and Olson, 2002). Most relevant to our investiga- onic development.
Taking advantage of the conditional gene targetingtion on splicing regulation, many heart genes are regu-
lated at the splicing level; several have served asmodels strategy, we recently found that SC35 ablation in the
cardiac lineage had little impact on heart developmentfor detailed biochemical studies (Hodges and Bern-
stein, 1994). but caused a clear disease phenotype (Ding et al., 2004).
Here we found that ASF/SF2 was also dispensable forIn this report, we present a functional dissection of a
prototypical SR protein, ASF/SF2, in the heart. In mature heart development when the floxed alleles were con-
verted to the null mutation in the cardiac lineage at thecardiomyocytes, individual SR proteins are nonessential
for cell viability, suggesting that most processing events onset of cardiogenesis (E8.5), because homozygous ko
mice were recovered in the expected Mendelian ratioin mammalian cells are not dependent on one particular
SR protein. Importantly, we have found that ASF/SF2 is (see Supplemental Table S2 on the Cell website) and
mutant mice appeared grossly normal at the weaninginvolved in the regulation of tissue-specific alternative
splicing of a rather restricted set of genes, including age. Note that the gene appeared to be partially deleted
(Figure 1C), which is likely due to the presence of othercardiac troponin T (cTnT), the Z-line protein Cypher,
and Ca2/calmodulin-dependent kinase II (CaMKII). cell types in thewhole heart, and thedata indicate80%
genedeletion in cardiomyocytes according to apreviousRemarkably, all regulated events seem to be coupled
with a general developmental cue to provide coordina- estimation (Chen et al., 1998).
Strikingly, in contrast to the SC35 heart-specific kotion with the functional transition from young heart to
adult, suggesting the operation of a postnatal, posttran- mice, which have a normal life span, all ASF/SF2 ko
mice died 6–8 weeks after birth (Figure 1D). We alsoscriptional reprogramming pathway in which ASF/SF2
is a critical player. Our findings illustrate how splicing noted a differential response to ASF/SF2 ablation in the
heart between male and female, a gender differencemay be differentially regulated by a seemingly “general”
factor in combination with other functional inputs in dif- frequently associated with cardiac disorders. These re-
sults demonstrate that the two related SR proteins playferent cell types or in the same cell type at different
developmental stages. Furthermore, our studyhas eluci- fundamentally distinct roles in cardiac muscle cells. Im-
portantly, this late disease onset phenotype nowpermitsdated an elegant strategy by which distinct isoforms of
CaMKII are expressed in developing heart to achieve detailed analysis of morphological and functional de-
fects resulting from SR protein ablation in the heart.spatial and temporal regulation of excitation-contrac-
tion (EC) coupling. By using a transgenic approach, we
have shown that expression of a single CaMKII isoform Development of Postnatal Contraction
is sufficient to phenocopy a specific spectrum of pheno- Defects and Dilated Cardiomyopathy
types observed in knockout (ko)mice, thereby establish- in ASF/SF2-Deficient Mice
ing the direct “genotype-phenotype” relationship be- The mutant heart appeared normal in the first 3 weeks
tween ASF/SF2-regulated splicing of CaMKII and EC of postnatal life in terms of organmorphology and heart/
coupling in cardiac muscle. body ratio (Supplemental Figure S1). Histopathological
analysis revealed normal cellular morphology at early
postnatal stages and a typical dilated cardiomyopathy
Results (DCM) in the mutant heart 6–7 weeks after birth, which
is characterized by dilation of all four chambers, thinner
Crucial and Nonredundant Roles of SR Proteins posterior wall of left ventricle and ventricular septum
in Development and Organ Physiology (Figure 2A), marked cellular hypertrophy and fiber disar-
In mammalian cells, crucial regulators of important bio- ray (Figure 2B), and fibrosis (Figure 2C). As with the
logical pathways often come as a family of functionally SC35 ko in the heart, we detected no sign of cell death
related proteins. This is no exception with splicing regu- in heart sections by the TUNEL assay (Ding et al., 2004;
lators, such as the SR family of splicing factors, which data not shown), indicating that the mutant phenotype
show both shared and distinct biochemical properties is unrelated to apoptosis. Thus, SR proteins are likely
in RNA binding and splicing reactions. How redundant nonessential for viability of cardiomyocytes. Some cell
or how unique each SR protein is in vivo and which loss and fibrosis may result from secondary effects of
protein, if any, is specifically involved in which biological heart failure at later disease stages.
pathways can be best addressed by genetic approaches. We next wished to characterize the onset of DCM in
For this purpose, we utilized the conditional gene tar- more detail. To this end, we performed echocardio-
geting strategy to investigate the biological function of graphic analysis on mutant mice (flox/flox Cre) and
wild-type littermate controls (flox/flox Cre or wt/floxthe prototypical SR protein ASF/SF2 in the mouse (Fig-
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Figure 1. Targeting of the ASF/SF2 Gene in the Heart Results in Postnatal Lethality
(A) Schematic graphs showing the structure of the ASF/SF2 gene and the conditional knockout strategy. Exons 2, 3, and 4 were removed
after recombination. RRM, RNA recognition motif. RS, arginine/serine-rich domain. The Neo and TK (thymidine kinase) genes were positive
and negative selection markers, respectively. Restriction sites indicated were used for construction of the targeting vector. The XbaI sites
were for genotyping in (C). Arrowheads, loxP sites. Arrows, PCR primers.
(B) PCR genotyping of ASF/SF2 conditional ko mice. wt, wild-type allele (the P2-P3 product); Type II, floxed allele (the P2-P3 product); Type
I, null allele (the P1-P3 product). Note that the potential P1-P3 products in wt and Type II would be too large for amplification.
(C) Southern blotting genotyping of cardiac-specific ablation. DNA was extracted from the ventricle of 1-month-old mice. DNA was digested
with XbaI and blotted with a probe from exon 1 of the ASF/SF2 gene. The smaller fragments in Type I and Type II deletion are due to the
XbaI site within the targeting vector as shown in (A). Induced deletion by Cre was comparable in hetero- and homozygous type II mice, which
was estimated to be 80% as described in the text.
(D) The Kaplan-Meier survival plot. The data show significant difference in survival between wt littermates (solid line), mutant male (dashed
line, p  0.001 by log-rank test), and female (dotted line, p  0.001 by log-rank test) ko mice. The difference in survival rate between males
and females is also significant (p  0.05 by log-rank test).
Cre, which are referred to as wt throughout the text gravated. This disease onset is coincident with the criti-
cal juvenile-to-adult transition, a major remodeling pe-and figures) in four age groups (Supplemental Table S3).
Interestingly, the heart malfunction was evident in mutant riod in response to increasing workload (Arber et al.,
1997). The disease timing therefore points to a criticalmice 4 weeks after birth and became progressively ag-
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Figure 2. Histopathological Analysis of ASF/
SF2-Deficient Heart
(A) H&E staining of coronal sections of normal
and mutant heart from 3- and 7-week-old
mice. While the morphology looks identical
at 3weeks, chamber enlargement and thinner
posterior wall are evident in the heart from a
7-week-old ASF/SF2 ko mouse in compari-
son with wt littermate controls.
(B) Enlarged sections of H&E staining reveal-
ing cardiomyocyte hypertrophy in a 5-week-
old ASF/SF2-deficient heart.
(C) Trichrome staining showing extensive fi-
brosis and myofibril disarray in the heart from
a mutant mouse 7 weeks after birth.
(D) EM analysis of the sarcomere structure in
WT and mutant heart from 6-week-old mice.
Shortening of the sarcomere and disorgani-
zation of the Z-disc (indicated bywhite arrow-
heads) are evident in themutant heart.Magni-
fication, 6610.
functional requirement for ASF/SF2 during this transi- locked in the contracted state, even though the heart
was fixed utilizing relaxing conditions under which alltion. Themost notable defect is the rapiddecrease in heart
contraction, which wasmeasured by fractional shortening wt sarcomeres displayed a normal relaxed morphology
(Figure 2D). Such a dramatic sarcomeric alteration was(%FS). The %FS of ASF/SF2 ko mice progressively de-
creased from 36.2% 7.5% to 17.1% 10.6% in 2weeks not observed in SC35-deficient heart (Ding et al., 2004)
but was highly reminiscent of the anatomic change trig-in comparisonwithaconstant%FSof55% inwt groups.
We alsoobservedmarkedbradycardia, reflecting severe gered by deletion of the tropinin I gene, which causes
a hypercontraction phenotype in cardiac myocytesAV block at advanced disease stages (our unpublished
data). The morphological and echocardiographic data (Huang et al., 1999). Thedata therefore suggest potential
hypercontraction in ASF/SF2-deficient cardiomyocytes,therefore suggest that the mortality may result from se-
vere defects in the contractile apparatus and regulatory which likely contributes to the general contraction de-
fect at the whole heart level, resulting in the activation ofcircuitry in ASF/SF2-deficient mice.
We next examined the contractile apparatus in the compensatory pathways leading to progressive cardiac
hypertrophy and chamber dilation. Importantly, thismor-mutant heart. Ultrastructural analysis utilizing electron
microscopy revealed striking structural alterations. Com- phological characterization provided important clues for
further functional analysis at the cellular and molecularpared to wt heart, ASF/SF2-deficient heart displayed
fuzzy Z-lines and shortened sarcomeres that appeared levels.
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Figure 3. Cardiomyocytes from ASF/SF2 Knockout Mice Display a Hypercontraction Phenotype
(A) Transillumination images of single myocytes isolated from 5-week-old wt and ASF/SF2 mutant hearts. In comparison with wt, cellular
hypertrophy is evident with the mutant cell displaying 20% longer diastolic cell length (n  24–26 cells from three hearts, p  0.001).
(B) Confocal measurement of intracellular Ca2 transients and contraction. Cells were loaded with fluo-4 and paced electrically at 1.0 Hz.
Time and space are displayed on the abscissa and ordinate of the line-scan images, respectively. Right panels show the traces of spatially
averaged Ca2 transients (top) and the corresponding cell shortenings (bottom, downward deflections).
(C and D) Statistical analysis of twitch amplitude (TA, percent of diastolic cell length) and peak Ca2 transient (F/F0, where F0 refers to fluo-4
signal at rest), respectively. n  24–27 cells from three hearts.
(E) Diastolic cytosol Ca2 level at 1 Hz pacing, indexed by indo-1 fluorescent ratio r410/490. n  12–14 cells from two hearts.
(F) Sarcoplasmic reticulum Ca2 store. Caffeine (20 mM) was applied to empty the stored Ca2 into the cytosol. The peak increase of indo-1
fluorescent ratio (	r410/490) was used as the index of the size of store Ca2 load. n  12–14 cells from two hearts. *p  0.05, **p  0.01, and
***p  0.001 KO (filled bars) versus wt (open bars) by Student’s t test.
Severe EC Coupling Defects Detected release through the ryanodine receptor 2 (RyR2) (Cheng
et al., 1993). Specifically, in quiescent ko cells, therewith Isolated Cardiomyocytes
To characterize the contraction defect, we isolated was a 1.5-fold increase of the occurrence of Ca2 sparks
over that in wt cells (Figures 4A and 4B), suggestingcardiomyocytes and conducted a series of functional
studies at the single-cell level. We chose 5-week-old that RyR2 is leaking at resting conditions. Moreover,
unitary Ca2 sparks were also greater in terms of ampli-mice for physiological measurements to avoid potential
secondary effects at more advanced disease stages. tude and width (Figures 4C and 4D). Thus, myocyte
hypercontraction in the mutant heart might be largelyWhen isolated cardiomyocytes were loaded with a Ca2
indicator (Fluo-4), placed under a confocal microscope, attributable to the enhanced sarcoplasmic reticulum
Ca2 recycling. The data thus point to a specific role ofand paced with 1 Hz field stimulation, we detected sig-
nificantly increased cellular hypertrophy (Figure 3A) and ASF/SF2 in regulated Ca2 handling in cardiomyocytes.
elevated twitch amplitude (Figures 3B and 3C) in mutant
cells in comparison towt littermate controls, demonstra- A Role of ASF/SF2 in the Regulation
of Tissue-Specific Alternative Splicingting the hypercontraction phenotype at the single cell
level. During this systematic physiological analysis, we of Key Sarcomere Components in the Heart
Detailed histopathological and physiological character-uncovered a marked alteration in Ca2 handling, a major
regulatory pathway for muscle contraction. While dia- ization of the ASF/SF2-deficient heart suggests poten-
tial molecular abnormalities in both mechanics and reg-stolic Ca2 was normal (Figure 3E), both the peak Ca2
transient (Figures 3B and 3D) and the caffeine-releas- ulatory circuitry in cardiac muscle. To identify the
molecular defects underlying the disease phenotype,able Ca2 content in the sarcoplasmic reticulum (Figure
3F) were markedly increased. we performed Northern and RT-PCR analyses on total
RNAextracted fromwhole ventricles of 4-week-oldmiceThe Ca2 handling defect was further corroborated
by ASF/SF2 deficiency-associated alterations in Ca2 to analyze the expression of major contractile compo-
nents (Supplemental Figure S2). We also took amicroar-sparks, elemental events of sarcoplasmic reticulum Ca2
Cell
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Figure 4. Elevated Ca2 Leak in ASF/SF2-Deficient Myocytes Measured by Spontaneous Ca2 Sparks
(A) Confocal line-scan, time-lapse images showing spontaneousCa2 sparks in single cells isolated fromASF/SF2KOandwtmice.Measurement
was conducted on Fluo-4 loaded cells at rest.
(B–D) Comparison of spark frequency (B), amplitude (expressed as F/F0) (C), and full width at half maximum (FWHM) (D) between groups. n 
449–1115 sparks with 21–22 cells from two hearts in each group. ***p  0.001 KO (filled bars) versus wt (open bars) by Student’s t test.
ray approach to identify downregulated transcripts that and 5 is conserved from chicken to human and is devel-
opmentally regulated such that exon inclusion is pre-may bedirectly or indirectly triggered by splicing defects
(Supplemental Figure S3). The results showed that the dominant in pre- and neonatal stages but is gradually
switched to exon exclusion in adult (Jin, 1996). We fol-expression of most genes was unaltered in the mutant
heart. Among upregulated genes detected by microar- lowed cTnT splicing during postnatal development by
RT-PCR and found that cTnT exon 4 was still efficientlyray and confirmed by Northern blot, many are markers
for cardiac hypertrophy and fibrosis, such as natriuretic included in ASF/SF2-ablated heart (Figure 5A). The case
with Cypher, which is regulated in a tissue-specificman-peptide precursor (also known as atrial natriuretic factor
or ANF) and skeletal actin. Crossanalysis indicates that ner by mutually exclusive usage of exon 4 in cardiac
muscle and exons 5–7 in skeletal muscle, was moremany of those markers are similarly upregulated in
SC35-deficient heart (indicated by * in Supplemental striking (Figure 5B). Interestingly, the cardiac isoform of
Cypher was switched to the skeletal isoform (Figure 5B),Figure S3, Ding et al. [2004]). Therefore, the upregulation
likely reflects a common compensatory pathway associ- and the switch at the protein level was confirmed by
Western blotting using isoform-specific antibodies (Fig-ated with DCM. RT-PCR analysis of major contractile
components and the few downregulated genes from ure 5C). The observed isoform switches were specific
to ASF/SF2 deficiency because no switch could be de-microarray again showed no change with most alterna-
tive splicing events examined (Supplemental Figure S2), tected either in SC35-deficient heart (Figures 5A and
5B) or in a splicing-unrelated heart failure model re-including the splicing pattern of 
-tropomyosin, which
was previously suggested to be regulated by both SC35 sulting from gene targeting of the muscle LIM protein
MLP (Arber et al. [1997], Supplemental Figure S2).and ASF/SF2 (Gallego et al., 1997). We conclude from
these results that, as with SC35, ablation of ASF/SF2 Most remarkably, neither observed splicing defects
took place until postnatal day 20 (see the ratio changedid not invoke widespread molecular defects in cardio-
myocytes. at the bottom of Figures 5A and 5B). This was unlikely
due to the maternal effect of ASF/SF2 deletion, as theOur survey did reveal two alternative splicing events
that were specifically affected by ASF/SF2 ablation in gene was deleted early in cardiogenesis (E8.5), and
postnatal cardiaomyocytes are largely nondividing cells.the heart. One is developmentally regulated splicing of
cardiac troponin T (cTnT) (Figure 5A), and the other is Our findings therefore reveal a tight coupling of ASF/SF2
function with a general developmental cue to regulatetissue-specific alternative splicing of the LIM domain
binding protein 3 (LDB3), which is also known as Cypher alternative splicing during the critical juvenile-to-adult
transition period. For cTnT, ASF/SF2plays a role in coor-in the mouse or ZASP in humans (Zhou et al., 1999;
Faulkner et al., 1999). In the case of cTnT, it is well dinating the developmental switch,whereas, for Cypher,
ASF/SF2 is required for maintaining its tissue-specificdocumented that alternative splicing of cTnT exons 4
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Figure 5. Tissue-Specific Alternative Splic-
ing Events Regulated by ASF/SF2
(A) Time course analysis of alternative splic-
ing of cardiac Troponin T (cTnT) by RT-PCR
(the primer set indicated by arrowheads). Il-
lustrated on the top is the pattern of mouse
cTnT alternative splicing involving exons 4
and 5. Exon usages predominant in embryos
and adult are indicated by solid and dotted
lines, respectively. Results of RT-PCR analy-
sis of cTnT isoforms at different postnatal
days are shown. RT-PCR analysis of RNA
from SC35-deficient heart at two different
stages is included for comparison. Isoform
ratio between (3-4-6) and (3-6), which indi-
cates the inclusion of exon 4, is calculated
and illustrated at the bottom. Reproducible
isoform switch is evident after postnatal day
30. Minor isoforms containing exon 5 are also
visible at more advanced stages in ASF/SF2-
deficient heart but not in wt heart.
(B) Time course analysis of Cypher alternative
splicing by RT-PCR (the primer set indicated
by arrowheads). Shown on the top is the tis-
sue-specific pattern of Cypher alternative
splicing in the mouse. Cypher is also known
to give rise to another nontissue specific iso-
form involving exon 10 (which contains a stop
codon marked by X). RT-PCR results are
shown in comparison between RNA from
ASF/SF2- and SC35-deficient hearts. Ratio
between cardiac versus skeletal (“ca. vs. sk.”)
isoform is shown at the bottom. Infinity sym-
bol (∞) indicates that the level of skeletal mus-
cle specific isoform is undetectable. Results
demonstrate that development-dependent
isoform switch as well as a reduction of the
total transcript at advanced stages.
(C) Western blotting analysis of Cypher in wt
and mutant heart from 1-month-old mice.
Protein isoforms were detected with isoform-
specific antibodies against epitopes in car-
diac specific exon 4 and skeletal specific ex-
ons 5–7, respectively. -tubulin was used as
a loading control.
splicing mode during developmental reprogramming of lated by phospholamban (PLB). PLB is in turn regulated
by two major kinase systems, PKA and CaMKII, whichother transcripts.
are also implicated in phosphorylation of several key
Ca2 handling proteins to streamline Ca2 cycling (Xiao,Correlation between the EC Coupling Defect and
2001). PLB phosphorylation by PKA at Ser16 and CaM-a Switch of CaMKII to a Neuronal-Specific Isoform
KII at Thr17 relieves its inhibition of SERCA2a, resultingWe next addressed the Ca2 handling defect, as Ca2
in enhanced Ca2 uptake to the sarcoplasmic reticulumsignaling is of paramount importance for cardiac func-
(Simmerman and Jones, 1998).tionality and is involved in complex regulation (Bers,
By Western blotting analysis of a number of key Ca22002). Based on the current knowledge (see the diagram
handling proteins in the heart, we found that both thein Figure 6A), heart contraction in adult animals is initi-
level of the proteins and their phosphorylation profileated by Ca2 entry into the cell through L-type channels,
were largely unaltered in ASF/SF2-deficient heart. Inter-which triggers Ca2-induced Ca2 release (CICR) from
estingly, the only exception is the reduction of PLBsarcoplasmic reticulum via RyR2. During relaxation, a
phosphorylation at Thr17 in the mutant heart (Figuresmall fraction of cytoplasmic Ca2 is pumped out of
6B). These observations rule out the involvement of thethe cell by Na/Ca exchanger (NCX), and the majority of
PKA pathway and possible alterations in protein phos-cytoplasmic Ca2 is recycled back to the sarcoplasmic
reticulum through the SERCA2a pump, which is regu- phatases but specifically point to potential functional
Cell
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Figure 6. Switch of CaMKII to a Neuronal-Specific Isoform in ASF/SF2-Deficient Heart
(A) Schematic illustration of main components involved in excitation-contraction (E-C) coupling in cardiac muscle. Concentrated at the
T-tubules are the following: NCX,Na-Ca2 exchanger,which plays aminor role inCa2 influx and clearance in adult heart; DHPR, dihydropyridine
receptor or L-type Ca2 channel, which is sensitive to membrane depolarization induced by the conduction system; RyR, ryanodine receptor
2, a major Ca2 release channel in the process of Ca2 induced-Ca2 release (CICR). ATP, the SERCA2a ATPase, which is the major channel
for Ca2 reuptake; SR, sarcoplasmic reticulum (note: not to be confusedwith the SR family of proteins); MF,myofilaments; PLB, phospholamban.
(B) Western blotting analysis of some critical components involved in E-C coupling. P-RyR2, phosphorylated RyR2. SERCA2a, sarcoplasmic
or endoplasmic reticulum calcium 2 ATPase. PLB, total phospholamban. PLB-Thr17, PLB phosphorylated by CaMKII at threonine 17. PLB-
Ser16, PLB phosphorylated by protein kinase A at Serine 16. -tubulin serves as a loading control.
(C) Time course analysis of CaMKII alternative splicing in ASF/SF2-deficient heart. Illustrated in the top are three alternative exons (14, 15,
and 16) in the CaMKII gene and the three major isoforms containing exons 15 and 16 (A), exon 14 (B), and no alternative exons (C).
Results of RT-PCR analysis show the expression of the neuronal-specific A isoform in later development in ASF/SF2-deficient heart, which
is not the case in SC35-deleted heart from adult mice.
(D) Western blotting analysis of CaMKII protein expression in wt and ASF/SF2-deficient heart.
(E) Localization of individual CaMKII isoforms. Cardiacmyocytes from the A transgenic mice were isolated and stained with an anti-HA
antibody. A clear striated pattern is observed. This is in contrast to the nuclear staining of the B isoform and the largely diffused cytoplasmic
localization of the C isoform in isolated myocytes transduced by adenovirus.
Regulated Splicing Critical for Cardiac EC Coupling
67
abnormality with CaMKII. However, the data was ini- transgenic mouse to express the A isoform under the
cardiac-specific myosin heavy chain promoter to testtially confusing, because a CaMKII defect is supposed
to weaken Ca2 handling. For instance, it has been the gain-of-function hypothesis in the wt background
(Figure 7A). Characterization of the transgenic lineshown that inhibition of CaMKII by the peptide inhibitor
KN-93 decreases steady-state twitch, Ca2 spark fre- showed that the mouse carries about 15 copies of the
HA-tagged AcDNA (Figure 7B). Compared to the condi-quency, and the sarcoplasmic reticulum Ca2 content
(Li et al., 1997). We observed a significant enhancement tional ASF/SF2 ko mice, the transgenic mice developed
a similar but relatively delayed postnatal cardiac hyper-in EC coupling in ASF/SF2-deficient cardiomyocytes
(Figure 3), which is thus incompatible to simple inactiva- trophy and contraction defect, as revealed by echocar-
diography (data not shown). Also similar to the situationtion of CaMKII.
To address this discrepancy, we examined the ex- in the conditional ASF/SF2 ko mice, a major gender
difference was associated with the transgenic animalspression of CaMKII, because the kinase is known to be
regulated by alternative splicing (Braun and Schulman, such that 50% of the transgenic males began to die 8
weeks after birth, while females were largely unaffected1995). The C isoform, which lacks all alternative exons,
is responsible for PLB phosphorylation in the cytoplasm (data not shown). For our current purpose, we focused
on characterization of the transgenic males.(Zhang et al., 2003). Inclusion of exon 14 (which contains
a functional nuclear localization signal) in the B isoform Characterization of the isolated cardiomyocytes from
the transgenic mice demonstrated differential targetingtargets the kinase to the nucleus (Srinivasan et al., 1994).
By RT-PCR, we detected one additional major isoform of the neonatal A isoform to the T-tubules (Figure 6E),
which is consistent with its presumptive effect on ECthroughout development in ASF/SF2-deficient heart
(Figure 6C). Cloning and sequencing showed that the coupling because all channels involved in Ca2 influx are
concentrated on the T-tubules. To demonstrate whethernew isoform corresponds to the A form resulting from
the inclusion of both exon 15 and 16. Consistent with this was indeed the case, we measured several critical
EC coupling parameters on cardiomyocytes isolatedthe RT-PCR result, we detected a slowermigrating band
in ASF/SF2-deficient heart by Western blotting using from 7- to 8-week-old transgenic mice and observed
overtly elevated twitch amplitude (Figures 7C and 7D),anti-CaMKII antibodies (Figure 6D). Remarkably, like
cTnT and Cypher, time course studies revealed that the peak Ca2 transient (Figures 7C and 7E), and caffeine-
releasable sarcoplasmic reticulum Ca2 content (Figureexpression of CaMKII isoforms is also developmentally
regulated. The neuronal-specific isoform is actually ex- 7G). These results recapitulated those observed in the
ASF/SF2 ko animals, therefore establishing that the aug-pressed in neonatal heart and begins to switch off 30
days after birth (Figure 6C). The retention of the A iso- mented expression of the CaMKIIA isoform is sufficient
to trigger the Ca2 handling defect in the wt context. Weform in later development was specific to ASF/SF2 abla-
tion because the isoform was properly switched off in conclude from these results that the defect in CaMKII
alternative splicing is largely responsible for enhancedboth SC35 and MLP heart failure models (Figure 6C;
Supplemental Figure S2). This observation reinforces sarcomplamic reticulum Ca2 cycling, thus leading to
the hypercontraction phenotype in ASF/SF2-deficientthe presence of a general reprogramming pathway for
alternative splicing in developing heart and demon- cardiomyocytes.
strates that ASF/SF2 is a crucial regulator in this pathway.
The A isoform was previously described as a neu- Discussion
ronal CaMKII isoform (Schworer et al., 1993). Expres-
sion of the HA-tagged A isoform in the heart (see below) Here we have described a pathway that helps define
demonstrated the striated pattern of localization of this aspects of critical modifications in gene expression re-
isoform, which is distinct from that of the B isoform in quired for developmental shift to homeostasis in ma-
the nucleus and the C isoform in the cytoplasm (Figure tured organs. Specifically, characterization of the heart
6E, Zhu et al. [2003]). The striated localization is clearly development model system has led to the discovery
indicative of the association of the A isoform with the of a posttranscriptional reprogramming pathway, which
T-tubules where key Ca2 channels and activated CaM- plays a fundamental role in heart remodeling.
KII are concentrated (Xiao et al., 1994). This was con-
firmed by colocalization with a T-tubule marker NCX SR Proteins as Alternative Splicing
(data not shown). Differential targeting of the A isoform Regulators In Vivo
to the T-tubules thus provides a plausible explanation Biochemical characterization of RNA binding proteins
to the observed Ca2 handling defects (see Discussion) involved in regulated splicing has provided a wealthy
and to the decrease in PLB phosphorylation as a result pool of candidates to design reverse genetic approaches
of sequestration of the kinase in the cytoplasm of ASF/ to explore their biological functions. Such an approach
SF2-deficient myocytes. was first applied to thebrain-specificKH-typeRNAbind-
ing protein Nova-1 (Jensen et al., 2000a). Characteriza-
tion of this mouse model has led to the identification ofSufficiency of the Neuronal-Specific CaMKII
Isoform in Causing Ca2 Signaling Defects several direct targets bound by this neuronal-specific
splicing regulator (Jensen et al., 2000b; Ule et al., 2003).in Transgenic Animals
The observed CaMKII splicing switch suggests that the However, it is currently unclear how the molecular de-
fects in each identified targets are related to the ob-Ca2 handling puzzlemight be due to a “gain of function”
of the neuronal-specific and neonatal isoform inmatured served neurological disorders. In our current study, we
have linked for the first time a specific splicing regulatorheart. We approached the problem by constructing a
Cell
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Figure 7. The Expression of CaMKIIA in
Transgenic Mice Phenocopies the Ca2 Han-
dling Defects in ASF/SF2-Deficient Myocytes
(A) Diagram of the transgenic construct.
MHC, mouse  myosin heavy chain pro-
moter. HA, hemagglutinin tag. SV40, polyade-
nylation signal of simian virus 40.
(B) Genotyping of transgenic mice (TG).
(C) Measurement of major Ca2 handling pa-
rameters in transgenic mice. Upper panels
show typical fluo-4 and confocal images of
CaMKIIA TG and wt littermate cells at 1.0
Hz pacing. Lower panels show the corre-
sponding traces of spatially averaged Ca2
transients (top) and the corresponding cell
shortenings (bottom, downward deflections).
(D–F) Statistic data of twitch amplitude (TA)
(D), peak Ca2 transient (F/F0) (E), and caf-
feine-elicited Ca2 transients after 1 Hz pac-
ing (indo-1 fluorescent ratio 	r410/490) (F). n 
30–40 cells from three hearts. *p  0.05 and
**p  0.01 TG (filled bars) versus wt (open
bars) by Student’s t test.
to a defined molecular target and then to a distinct SRp55 in Drosophila (Kim et al., 2003). Instead, SR pro-
teins were found to participate in the regulation of aphenotype in the mammalian system.
Genetic studies have now firmly established the fun- very restricted set of targets in both fly and mammals
as demonstrated by Kim et al. (2003) and our groupdamental function of the SR family of splicing factors in
development as germline deletion of SRp20 (Jumaa et (Wang et al., 2001; Ding et al., 2004; this report). There-
fore, SR proteins appear to act as a class of highlyal., 1999), SC35 (Wang et al., 2001), and ASF/SF2 (this
report) all caused early embryonic lethality. Given that specific splicing regulators in vivo.
In the present study, we proved genetically that ASF/SR proteins are essential splicing factors, it has been
anticipated that inactivation of SR proteins would cause SF2 is specifically involved in a number of tissue-spe-
cific alternative splicing events in the heart. Interestingly,some general defects in cell metabolism and therefore
cell death. This is consistent with the observation in the factor seems to play a key role in splicing switches
that are tightly coupled with a developmental program,chicken DT40 cells (Wang et al., 1996) and in mouse
embryo fibroblasts (our unpublished data) in which gene indicating that ASF/SF2 cannot act alone in the regula-
tion. The current case for the involvement of a ubiqui-targeting of ASF/SF2 resulted in cell lethality. Surpris-
ingly, however, we found that tissue-specific ablation tously expressed splicing regulator in tissue-specific
regulation of splicing may be analogous to the coopera-of SC35 (Ding et al., 2004) and ASF/SF2 (this report) in
the heart all gave rise to developmental and disease tion between Tra (which is female specific) and Tra-2
(which is expressed in both sexes) in the regulation ofphenotypes, which are not caused by large-scale apo-
ptosis. These findings thus point to the possibility that Dsx alternative splicing in the fly (Lynch and Maniatis,
1996). Further mechanistic studies to understand howindividual SR proteins may each play a defined role in
specific cells and tissues but are not generally required ASF/SF2 functions in tissue-specific alternative splicing
would require the identification of a proper cellularfor cell viability in all cell types.
The notion that SR proteins function in specific path- model in which the regulation can be mimicked by the
activation of certain differentiation signaling pathways.ways insteadof being generally required for cellmetabo-
lism is supported by our finding that the expression of
most gene transcripts was unaltered in both SC35- and General Reprogramming Pathway for Alternative
Splicing in Developing HeartASF/SF2-ablated cardiomyocytes (Ding et al., 2004; this
report). Similar observations have also been made with It is well known that developing heart has to undertake
a series of remodeling events to meet the demand forASF/SF2 in DT40 cells (Lemaire et al., 2002) and B52/
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increasing workload. It has been long recognized that the two other CaMKII isoforms (Zhang et al., 2002,
2003; Maier et al., 2003). Overexpression of the B iso-such remodeling is accompanied by a reprogramming
pathway for gene expression (Siedner et al., 2003). For form in the nucleus or the C isoform in the cytoplasm
in transgenic mice both gave rise to marked decreaseexample, the fetal troponin I (ssTnI) is gradually replaced
by the adult cardiac-specific cTnI in postnatal develop- in diastolic Ca2, transient amplitude, and caffeine-
releasable Ca2 content in the sarcoplasmic reticulum,ment. Similarly, the expression of 
-tropomyosin is
switched to the  form during the same period. This all of which seem to reflect a general heart failure pheno-
type (Zhang et al., 2002, 2003). In contrast, we detectedgene expression reprogramming is crucial for highly
synchronized muscle contraction in adulthood, as both enhanced EC coupling and hypercontraction in isolated
cardiomyocytes. Because the isoform choice affects in-the troponin complex and tropomyosin are known to
play critical roles in muscle contraction in response to tracellular targeting but not the biochemical properties
of the kinase (Bayer and Schulman, 2001), it is likely thatoscillation of cytoplamic Ca2 (Reiser et al., 1994).
One of the unexpected findings in the current report the phenotype in the A transgenic mice results from
the targeting of the kinase to the T-tubuleswhere severalis the posttranscriptional reprogramming that is associ-
ated with target transcripts regulated by ASF/SF2. De- key Ca2 handling proteins are located.
The action of CaMKII at the submicrodomain of thevelopmental regulation of cTnT alternative splicing is
well documented (Jin, 1996). Here, we found that abla- T-tubules to affect EC coupling is well supported by
documented function of the kinase in cardiomyocytes.tion of ASF/SF2 perturbed cTnT isoform switch during
postnatal heart remodeling. Strikingly, the other two It has been shown that CaMKII plays a critical role
in Ca2-dependent facilitation of L-type Ca2 channelsidentified ASF/SF2 targets, Cypher and CaMKII, also
display a similar development-dependent defect. In the (Anderson, 2004), which is consistent with the observed
enhanced EC coupling in our transgenic mice. In addi-case of Cypher, ASF/SF2 is required for maintaining the
splicing mode in a cardiac-specific manner, whereas, tion, it has been recently reported that RyR2 Ca2 sensi-
tivity and openprobability can be increasedbyCaMKII-for CaMKII, ASF/SF2 facilitates the off switch of its
neuronal-specific isoform. In all these cases, the similar mediated phosphorylation of RyR2 at a site distinct from
that phosphorylated by PKA (Wehrens et al., 2004),timing in isoform switch strongly suggests a general
developmental reprogramming pathway for regulated which is also in agreement with our findings. Together,
these data suggest a highly plausible mechanism forsplicing during heart remodeling.
The observed posttranscriptional reprogramming is the enhanced EC coupling in the A transgenic mice in
which differential targeting of the kinase isoform to thefunctionally critical for the heart function in light of other
published results. With regard to cTnT, a recent study T-tubules induces coupled gating via specific phosphor-
ylation of various Ca2 channels, and influx of Ca2demonstrated that muscle fibers containing exon 4
showed less relaxation in the absence of Ca2 (Gomes through these channels further activates the CaMKII,
thereby establishing a positive feedback loop and re-et al., 2002). Thus, elevated exon 4 inclusion may con-
tribute to the hypercontraction phenotype in our komice sulting in enhanced EC coupling.
The expression of the neuronal-specific CaMKII iso-due to the inefficiency in the relaxation phase of muscle
contraction. In the case of Cypher, the expression of form in the heart is more than a pathological event in-
duced by the deletion of ASF/SF2. Instead, our studythe skeletal isoform in cardiacmusclemay cause incom-
patibility in Z-line organization. Indeed, genetic replace- has revealed that a switch in splicing of the CaMKII
transcript is a critical component for the maturation ofment of the cardiac isoform of Cypher with the skeletal
isoform caused 50% postnatal mortality in the mouse cardiac function in meeting demand in the postnatal
environment. While it is well known that the main Ca2(Huang et al., 2003a), demonstrating the physiological
importance of distinct Cypher isoforms in different mus- source in neonatal heart is dependent on Ca2 influx
through L-type channels, which is switched to Ca2-cle types. Our results now show that ASF/SF2 is a key
regulator in tissue-specific alternative splicing of Cypher induced Ca2 release (CICR) involving both the sarco-
lemmal L-type channels and RyR2 in adult heart (Had-in the heart.
dock et al., 1999), themechanism for such a Ca2 source
switch has remained mysterious. Our findings concern-Regulation of EC Coupling by Differential CaMKII
ing the alternative splicing of CaMKII suggest the intri-Splicing in Developing Heart
guing possibility that the temporal change in mRNA iso-Members of the CaMKII family are remarkable in that
form expression is a key event in programmed Ca2they use a number of strategies to achieve spatial regu-
source switch in the developing heart. The model sys-lation of cellular activities. Unlike CaMKI and V, both of
tem, the approaches, and the findings should be instru-which act asmonomers, CaMKII functions as amultimeric
mental to future functional studies of regulated splicingenzyme consisting of 12 subunits (Braun and Schulman,
in biology, because the rules are likely to subserve “com-1995). The formation of the holoenzyme would allow in
parable switching events” in postnatal adaptations inprinciple a fractional isoform change to influence the
many organ systems.general behavior of the enzymatic complex. In our pres-
ent study, we found that the switch to the CaMKIIA
Experimental Proceduresisoform is sufficient to cause enhanced EC coupling.
The biological effect is not simply due to overexpression
Construction of Gene Targeting and Transgenic Mice
of the kinase in the cell, because the phenotypic charac- A full-length human ASF/SF2 cDNA was used to screen a mouse
teristics of the A transgenic mouse are fundamentally 129SV/J genomic library (Stratagene). Two independent cloneswere
isolated and restriction mapped. The targeting construct was builtdistinct from those resulting from the overexpression of
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in a loxP vector (Wang et al., 2001) by inserting a 4.8 kb Not I-Aat conjugated secondary antibodies (Jackson Laboratories). Confocal
images (LSM510, Carl Zeiss) were obtained with 633 and 543 nmII fragment as the 5 arm; a 2.5 kb Aat II-EcoR I fragment harboring
exons 2, 3, and 4 as the targeting region; and a 6.3 kb EcoR I-Xba laser lines to excite the Cy5 and Cy3 fluorophores, respectively (Xiao
et al., 1994).I fragment as the 3 arm. Linearized targeting vector was eletropor-
ated into J1 embryonic stem (ES) cells. Southern blotting identified
eight out of 192 G418-resistant clones that had undergone homolo- Ca2 and Contraction Measurement
gous recombination. Two ES clones were transiently transfected Enzymatically isolatedmyocyteswere loadedwith theCa2 indicator
with a Cre expression plasmid to generate the floxed allele (type fluo-4/AM (5mol/L for 15min) (Molecular Probes) and electronically
II deletion). Type II ES clones were microinjected into C57BL/6J stimulated at 1 Hz in perfusion solution (Zhou et al., 1997). Confocal
blastocysts, which were implanted into the uteri of foster mothers. images were obtained in the line-scan mode (Ding et al., 2004).
Both ES clones were transmitted into germline. For genotyping, a Image processing, data analysis, and presentation were performed
set of three primers was used for PCR analysis of mouse-tail DNA: using IDL 5.5 software (Research Systems). Data were reported as
ASF/SF2-P1 (5-TTCGCCTTCGTTGAGTTC-3), ASF/SF2-P2 (5-ACT mean  SEM. Student’s t test was applied to determine statistical
AATGTGGGAAGAATGGC-3), and ASF/SF2-P3 (5-AAACTATTGCT significance of measured differences. A p value of less than 0.05
CCCATCTGC-3). Conversion to germline- and cardiac-specific ko was considered statistically significant.
was as described using the Zp3- and MLC-2v-Cre mice (Ding et al.,
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